Skip to main content
Concurrent Romiplostim With FOLFIRINOX for Secondary Prevention of Thrombocytopenia in a Patient With Myelodysplastic Syndrome and Pancreatic Adenocarcinoma
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Concurrent Romiplostim With FOLFIRINOX for Secondary Prevention of Thrombocytopenia in a Patient With Myelodysplastic Syndrome and Pancreatic Adenocarcinoma
User login
Username
Password
Reset your password
Concept
Lead
score
Thrombocytopenia
1
1
Platelet Count
0
0.77
Myelodysplastic Syndrome
0
0.59
Thromboembolism
0
0.54
Chemotherapy
0
0.34
Pancreatic Cancer
0
0.34
Transfusion
0
0.34
Adenocarcinoma of the Pancreas
0
0.32
Adenocarcinoma
0
0.23
Hemorrhage
0
0.23
Spine
0
0.2
Bone Marrow
0
0.16
Cervical Spine
0
0.16
Biopsy
0
0.12
Bone
0
0.12
Embolization
0
0.12
Neoadjuvant Therapy
0
0.12
Neuropathy
0
0.12
Receptors
0
0.12
Specialty
Lead
score
Hematology-Oncology
1
1
Diabetes & Endocrinology
0
0.66
Family Medicine/Primary Care
0
0.59
Internal Medicine
0
0.59
Pharmacist
0
0.47
Gastroenterology
0
0.4
Neurology & Neurosurgery
0
0.32
Orthopaedics
0
0.2
Pathology & Lab Medicine
0
0.12
Edit Tags